Cambridge Investment Research Advisors, Inc. Novartis Ag Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 52,867 shares of NVS stock, worth $5.45 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
52,867
Previous 51,040 3.58%
Holding current value
$5.45 Million
Previous $5.43 Million 11.91%
% of portfolio
0.02%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
BUY
$106.13 - $120.89 $193,899 - $220,866
1,827 Added 3.58%
52,867 $6.08 Million
Q2 2024

Jul 26, 2024
SELL
$92.57 - $107.37 $589,948 - $684,269
-6,373 Reduced 11.1%
51,040 $5.43 Million
Q1 2024

Apr 24, 2024
BUY
$95.27 - $108.47 $156,242 - $177,890
1,640 Added 2.94%
57,413 $5.55 Million
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $720,351 - $792,722
-7,807 Reduced 12.28%
55,773 $5.63 Million
Q3 2023

Oct 24, 2023
SELL
$94.73 - $105.13 $1.91 Million - $2.12 Million
-20,147 Reduced 24.06%
63,580 $6.48 Million
Q2 2023

Jul 13, 2023
BUY
$92.52 - $104.91 $2.73 Million - $3.09 Million
29,488 Added 54.37%
83,727 $8.45 Million
Q1 2023

May 11, 2023
SELL
$80.03 - $92.81 $165,261 - $191,652
-2,065 Reduced 3.67%
54,239 $4.99 Million
Q4 2022

Feb 08, 2023
SELL
$75.55 - $92.52 $7,479 - $9,159
-99 Reduced 0.18%
56,304 $5.11 Million
Q3 2022

Oct 17, 2022
SELL
$74.61 - $87.26 $61,404 - $71,814
-823 Reduced 1.44%
56,403 $4.29 Million
Q2 2022

Jul 13, 2022
BUY
$80.52 - $93.75 $240,432 - $279,937
2,986 Added 5.51%
57,226 $4.84 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $8,491 - $9,605
-106 Reduced 0.2%
54,240 $4.76 Million
Q4 2021

Feb 03, 2022
BUY
$79.7 - $88.13 $331,711 - $366,797
4,162 Added 8.29%
54,346 $4.75 Million
Q3 2021

Nov 02, 2021
SELL
$81.78 - $95.14 $329,982 - $383,889
-4,035 Reduced 7.44%
50,184 $4.1 Million
Q2 2021

Aug 10, 2021
SELL
$85.24 - $94.15 $347,012 - $383,284
-4,071 Reduced 6.98%
54,219 $4.95 Million
Q1 2021

May 07, 2021
BUY
$83.5 - $98.47 $54,358 - $64,103
651 Added 1.13%
58,290 $4.98 Million
Q4 2020

Feb 04, 2021
SELL
$78.07 - $94.43 $705,206 - $852,986
-9,033 Reduced 13.55%
57,639 $5.44 Million
Q3 2020

Oct 29, 2020
BUY
$82.14 - $91.0 $295,211 - $327,054
3,594 Added 5.7%
66,672 $5.8 Million
Q2 2020

Jul 27, 2020
BUY
$80.93 - $91.1 $56,651 - $63,769
700 Added 1.12%
63,078 $5.51 Million
Q1 2020

May 08, 2020
BUY
$70.67 - $99.01 $378,437 - $530,198
5,355 Added 9.39%
62,378 $5.14 Million
Q4 2019

Feb 04, 2020
BUY
$84.35 - $95.37 $321,879 - $363,931
3,816 Added 7.17%
57,023 $5.4 Million
Q3 2019

Nov 06, 2019
BUY
$85.54 - $94.26 $430,266 - $474,127
5,030 Added 10.44%
53,207 $4.62 Million
Q3 2019

Oct 28, 2019
BUY
$85.54 - $94.26 $42,684 - $47,035
499 Added 1.05%
48,177 $4.19 Million
Q2 2019

Aug 15, 2019
SELL
$75.4 - $92.8 $2.44 Million - $3.01 Million
-32,408 Reduced 40.47%
47,678 $0
Q1 2019

May 08, 2019
BUY
$75.32 - $86.15 $2.47 Million - $2.83 Million
32,817 Added 69.43%
80,086 $0
Q4 2018

Feb 05, 2019
BUY
$73.66 - $82.02 $152,918 - $170,273
2,076 Added 4.59%
47,269 $3.63 Million
Q3 2018

Nov 02, 2018
BUY
$66.94 - $77.43 $89,097 - $103,059
1,331 Added 3.03%
45,193 $0
Q2 2018

Aug 10, 2018
SELL
$64.91 - $73.36 $207,452 - $234,458
-3,196 Reduced 6.79%
43,862 $0
Q1 2018

May 09, 2018
BUY
$70.39 - $84.15 $114,946 - $137,416
1,633 Added 3.59%
47,058 $0
Q4 2017

Feb 22, 2018
BUY
$72.33 - $77.64 $51,788 - $55,590
716 Added 1.6%
45,425 $0
Q3 2017

Nov 07, 2017
BUY
$74.14 - $77.27 $383,971 - $400,181
5,179 Added 13.1%
44,709 $3.84 Million
Q2 2017

Aug 08, 2017
BUY
N/A
39,530
39,530 $3.3 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email